Clinical SCORE presents Partner of Choice™

Wednesday, April 12, 2017 General News
Email Print This Page Comment
Font : A-A+

CHADDS FORD, Pa., April 12, 2017 /PRNewswire/ -- Clinical SCORE presents an innovative process for measuring the effectiveness

of Medical Affairs (MA) teams. Partner of Choice™ addresses the pharmaceutical industry's need for a non-monetary way to assess performance while maintaining regulatory compliance and to assist teams with the critical insights necessary to deliver greater
value to key opinion leaders (KOLs).

"We've watched Medical Affairs groups play an increasingly important role in recent years. At the same time, tighter budgets put them under tremendous performance pressure," said Gary Kaplan, Vice President of Medical Affairs Research at Clinical SCORE. "Today's consultative model is highly nuanced, measures like call numbers aren't adequate. This new paradigm calls for a new approach to metrics."

Unlike traditional approaches, Partner of Choice uses non-monetary metrics and key performance indicators (KPIs) to quantify the value of medical affairs initiatives. It achieves this goal in conformance with compliance requirements for medical science liaison (MSL) objectivity. The exclusive process provides an MSL-independent way to assess KOLs' views of various scientific approaches to disease states. It does not name any specific product, company or MSL team — an agnostic approach that meets compliance standards.

Research results are presented via Clinical SCORE's proprietary KPI Konsole™. This unique format helps MA teams answer questions regarding how KOLs in a given specialty area view the advantages or disadvantages of a medication's mechanism of action or whether they agree on a common approach to treatment. It then tracks decision metrics over time, providing a means to gauge how events such as a product launch impacts the decisions.

"Partner of Choice meets the industry's need to quantify the value of Medical Affairs through non-monetary metrics and KPIs in a way that is designed to meet the requirements of the organization's compliance department," Kaplan said.

For more information on Partner of Choice, visit www.clinical-score.com.

About Clinical SCOREClinical SCORE provides the pharmaceutical industry with breakthrough analytics for drug development. The company's proprietary processes combine traditional market research methodologies with statistical evidence to give sponsors the detailed insights necessary to improve drug development progression. The company's research offerings include ATTUNE Analytics to enhance clinical operations and CRO/sponsor relationships, CLINICAL TRIAL INSIGHTS (CTI) and CTI PLUS to optimize post-clinical and commercial marketing efforts, and PARTNER OF CHOICE™ to empower MA Teams with Breakthrough Analytics.

Media Inquiries:   Taryn Chance, MPhil, M LDSenior Director, Business DevelopmentClinical SCORE, LLC 877-334-0100 taryn.chance@clinical-score.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/clinical-score-presents-partner-of-choice-300438501.html

SOURCE Clinical SCORE



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook